November 5, 2025 · Form 4 insider transaction
Kaplan Matthew L. bought 11,000 shares of Nuvectis Pharma, Inc. at $5.84 per share, a transaction worth $64.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reflects the weighted average purchase price. The range of prices for the shares purchased was $5.81 to $5.88. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.